Thu Sep 19 05:44:59 UTC 2024: ## SHL Telemedicine Outperforms Concord Medical Services in Stock Analysis: MarketBeat News

**New York, NY – September 19, 2024** – In a recent analysis by MarketBeat News, SHL Telemedicine (NASDAQ: SHLT) emerged as the stronger stock compared to Concord Medical Services (NYSE: CCM), both being small-cap medical companies. The analysis examined factors such as risk, profitability, analyst recommendations, institutional ownership, dividends, valuation, and earnings.

SHL Telemedicine demonstrated a higher level of institutional ownership, suggesting a strong belief in its long-term growth potential. Additionally, analysts have assigned a consensus target price of $11.00 for SHL Telemedicine, indicating a potential upside of 193.33%, compared to Concord Medical Services. SHL Telemedicine’s lower volatility, as measured by beta, also contributes to its favorable outlook.

The analysis concluded that SHL Telemedicine outperforms Concord Medical Services in 5 out of 8 key factors.

**Company Overview:**

Concord Medical Services focuses on radiotherapy and diagnostic imaging services in China, operating through a network of centers. They offer a range of services, including linear accelerators, proton therapy systems, and diagnostic imaging services.

SHL Telemedicine develops and markets personal telemedicine solutions in Israel, Europe, and internationally. Their offerings include smartheart, a personal mobile 12 lead ECG device, and other devices for remote monitoring of various health parameters.

**Investor takeaway:** Based on this comprehensive analysis, investors may find SHL Telemedicine a more favorable investment opportunity than Concord Medical Services.

**Disclaimer:** This news article is based on information provided by MarketBeat News and is intended for informational purposes only. It should not be considered as financial advice. Investors should conduct their own due diligence before making any investment decisions.

Read More